News

Arunjyoti Bio Ventures announced that the 40th Annual General Meeting(AGM) of the company will be held on 12 August 2026.

Net profit of Arunjyoti Bio Ventures declined 70.24% to Rs 0.61 crore in the quarter ended June 2026 as against Rs 2.05 crore during the previous quarter ended June 2025. Sales declined 5.86% to Rs 8.20 crore in the quarter ended June 2026 as against Rs 8.71 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales8.208.71 -6 OPM %25.2441.33 - PBDT1.652.99 -45 PBT0.812.17 -63 NP0.612.05 -70 Powered by Capital Market - Live News

Arunjyoti Bio Ventures will hold a meeting of the Board of Directors of the Company on 9 July 2026.

Net Loss of Arunjyoti Bio Ventures reported to Rs 5.40 crore in the quarter ended March 2026 as against net loss of Rs 1.99 crore during the previous quarter ended March 2025. Sales rose 37.12% to Rs 7.24 crore in the quarter ended March 2026 as against Rs 5.28 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 4.54 crore in the year ended March 2026 as against net loss of Rs 0.28 crore during the previous year ended March 2025. Sales declined 0.47% to Rs 27.75 crore in the year ended March 2026 as against Rs 27.88 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales7.245.28 37 27.7527.88 0 OPM %-32.736.44 -10.4118.01 - PBDT-2.69-0.24 -1021 0.962.71 -65 PBT-3.56-1.04 -242 -2.40-0.34 -606 NP-5.40-1.99 -171 -4.54-0.28 -1521 Powered by Capital Market - Live News

Arunjyoti Bio Ventures has postponed the meeting of the Board of Directors which was scheduled to be held on 8 May 2026. The meeting will now be held on 12 May 2026.